Selected article for: "cc NC ND International license and cell entry"
Author: Lu Li; Shuang Li; Manman Xu; Pengfei Yu; Sujun Zheng; Zhongping Duan; Jing Liu; Yu Chen; Junfeng Li
Title: Risk factors related to hepatic injury in patients with corona virus disease 2019
  • Document date: 2020_3_3
    • ID: 73gxq2w6_24
    Snippet: In our study, the hepatic injury of patients was mainly reflected through mild or medium elevation of ALT, and the level of serum TBIL was almost normal. Moreover, the pathological results of liver biopsy showed moderate microvascular steatosis and active inflammation in the hepatic lobule portal area 13 . Due to the use of lopinavir/ritonavir during treatment, it is difficult to distinguish the reason of liver injury according to the pathologica.....
    Document: In our study, the hepatic injury of patients was mainly reflected through mild or medium elevation of ALT, and the level of serum TBIL was almost normal. Moreover, the pathological results of liver biopsy showed moderate microvascular steatosis and active inflammation in the hepatic lobule portal area 13 . Due to the use of lopinavir/ritonavir during treatment, it is difficult to distinguish the reason of liver injury according to the pathological results. Although the cell entry receptor angiotensin converting enzyme-II is highly expressed in bile duct cells, recent works . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • active inflammation and liver injury: 1
    • ALT medium mild elevation and liver injury: 1, 2
    • ALT medium mild elevation and medium mild elevation: 1, 2
    • bile duct cell and duct cell: 1, 2, 3, 4
    • cc NC ND International license and cell entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc NC ND International license and cell entry receptor: 1, 2
    • cc NC ND International license and hepatic injury: 1, 2
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell entry and hepatic injury: 1
    • cell entry and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cell entry and liver injury: 1, 2, 3
    • cell entry receptor and hepatic injury: 1
    • cell entry receptor and International license: 1, 2, 3, 4
    • cell entry receptor and liver injury: 1, 2
    • hepatic injury and International license: 1, 2
    • hepatic injury and liver biopsy: 1, 2, 3
    • hepatic injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver injury and medium mild elevation: 1, 2